Molecular Pathology Testing – HER2/Neu Gene Amplification
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract entails providing molecular pathology testing to detect HER2/Neu gene amplification using either Fluorescence In Situ Hybridization (FISH) or Immunohistochemistry (IHC) methods. This testing is specifically for patients diagnosed with breast and gastric cancers. The services will support diagnostic and treatment decisions by identifying HER2 status, which is critical for targeted therapy options. Issued by the Department of Veterans Affairs under the NETWORK Contract Office 22 (36C262), the subcontract relates to NAICS code 621511, which corresponds to Medical Laboratories. The performance location is set in Phoenix, with a postal code of 85012. Proposals for this subcontract were sought with a submission deadline of June 26, 2026, following its announcement on June 15, 2026. This contract aims to enhance precision oncology resources available to Veterans through timely and accurate molecular testing.
General Info
Agency
NAICS
Place of Performance
Phoenix, AZ, 85012, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
